| __timestamp | Sarepta Therapeutics, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 49315000 | 13774000 |
| Thursday, January 1, 2015 | 75043000 | 22479000 |
| Friday, January 1, 2016 | 83749000 | 27388000 |
| Sunday, January 1, 2017 | 122682000 | 35610000 |
| Monday, January 1, 2018 | 207761000 | 49007000 |
| Tuesday, January 1, 2019 | 284812000 | 61139000 |
| Wednesday, January 1, 2020 | 317875000 | 68836000 |
| Friday, January 1, 2021 | 282660000 | 97592000 |
| Saturday, January 1, 2022 | 451421000 | 106903000 |
| Sunday, January 1, 2023 | 481871000 | 120998000 |
Unlocking the unknown
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Sarepta Therapeutics, Inc. and Vericel Corporation have taken different paths in optimizing these costs.
From 2014 to 2023, Sarepta's SG&A expenses surged by over 870%, reflecting its aggressive growth strategy. In contrast, Vericel's expenses increased by approximately 780%, indicating a more measured approach. Notably, in 2023, Sarepta's SG&A expenses were nearly four times higher than Vericel's, highlighting its expansive operational scale.
While both companies have seen significant increases, the data suggests that Vericel has maintained a more consistent and controlled growth in SG&A costs. This strategic management could position Vericel favorably in terms of operational efficiency, potentially offering a competitive edge in the biotech sector.
Amgen Inc. vs Vericel Corporation: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Zoetis Inc. or Sarepta Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc. Trends and Insights
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Vericel Corporation
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Vericel Corporation
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Sarepta Therapeutics, Inc. or MorphoSys AG: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Sarepta Therapeutics, Inc. or Evotec SE
Cost Management Insights: SG&A Expenses for Vericel Corporation and HUTCHMED (China) Limited
Comparing SG&A Expenses: Vericel Corporation vs Amphastar Pharmaceuticals, Inc. Trends and Insights